Evaluating Rare Disease Diagnostic Performance in Symptom Checkers: A Synthetic Vignette Simulation Approach
This addresses a critical challenge for symptom checker developers by enabling efficient, low-cost pre-deployment evaluation to prevent performance degradation in rare disease diagnosis.
The study tackled the problem of evaluating diagnostic performance for rare diseases in symptom checkers before algorithm updates, proposing a synthetic vignette simulation approach that accurately predicted performance changes with strong correlations (e.g., R²=0.83 for Recall@8).
Symptom Checkers (SCs) provide medical information tailored to user symptoms. A critical challenge in SC development is preventing unexpected performance degradation for individual diseases, especially rare diseases, when updating algorithms. This risk stems from the lack of practical pre-deployment evaluation methods. For rare diseases, obtaining sufficient evaluation data from user feedback is difficult. To evaluate the impact of algorithm updates on the diagnostic performance for individual rare diseases before deployment, this study proposes and validates a novel Synthetic Vignette Simulation Approach. This approach aims to enable this essential evaluation efficiently and at a low cost. To estimate the impact of algorithm updates, we generated synthetic vignettes from disease-phenotype annotations in the Human Phenotype Ontology (HPO), a publicly available knowledge base for rare diseases curated by experts. Using these vignettes, we simulated SC interviews to predict changes in diagnostic performance. The effectiveness of this approach was validated retrospectively by comparing the predicted changes with actual performance metrics using the R-squared ($R^2$) coefficient. Our experiment, covering eight past algorithm updates for rare diseases, showed that the proposed method accurately predicted performance changes for diseases with phenotype frequency information in HPO (n=5). For these updates, we found a strong correlation for both Recall@8 change ($R^2$ = 0.83,$p$ = 0.031) and Precision@8 change ($R^2$ = 0.78,$p$ = 0.047). Our proposed method enables the pre-deployment evaluation of SC algorithm changes for individual rare diseases. This evaluation is based on a publicly available medical knowledge database created by experts, ensuring transparency and explainability for stakeholders. Additionally, SC developers can efficiently improve diagnostic performance at a low cost.